Martı Technologies Inc. has elected Alex Spiro to its board of directors, just weeks after Elon Musk's longtime attorney visited the headquarters of the Turkish mobility super app. The announcement of ...

The FDA delivered a blow to Spero's hopes of bringing the carbapenem to market in a complete response letter (CRL) delivered this week, which said another trial would be required to support approval.

Evercore ISI analyst Gavin Clark-Gartner downgraded Spero Therapeutics (SPRO – Research Report) to a Hold on December 20 and set a price target of $5.00. The company’s shares closed last ...

The Istanbul-based Marti Technologies announced late last week that its board elected Alex Spiro as a director during its 2024 annual shareholder meeting. In New York, Spiro is representing Adams ...